<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>21967873</identifier>
<setSpec>0002-5151</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pietropaolo-Cienfuegos, Dino R</dc:author>
<dc:author>Hidalgo-Castro, Emilia María</dc:author>
<dc:author>Del Río-Navarro, Blanca</dc:author>
<dc:author>González-Díaz, Sandra Nora</dc:author>
<dc:author>Ortega-Martell, José Antonio</dc:author>
<dc:author>Huerta-Hernández, Rosa Elena</dc:author>
<dc:author>Rodríguez-Pérez, Noel</dc:author>
<dc:author>Larenas-Linnemann, Désirée</dc:author>
<dc:author>Arias-Cruz, Alfredo</dc:author>
<dc:author>Ambriz-Moreno, Maria de Jesús</dc:author>
<dc:author>Estrada, Alan</dc:author>
<dc:author>Treviño-Salinas, Marisol Belinda</dc:author>
<dc:author>Macías-Weinmann, Alejandra</dc:author>
<dc:author>Becerril-Ángeles, Martín</dc:author>
<dc:author>Báez-Loyola, Carlos</dc:author>
<dc:author>Zárate-Hernández, María Del Carmen</dc:author>
<dc:author>Oyoqui-Flores, Joel</dc:author>
<dc:author>Stone-Aguilar, Héctor</dc:author>
<dc:author>Cossío-Ochoa, Enna</dc:author>
<dc:description xml:lang="en">BACKGROUND Several international guidelines on immunotherapy exist, but they only apply partially in Mexico. The Mexican guideline of immunotherapy dates from 1998. OBJECTIVES To establish clinical recommendations and suggestions for Allergy residents and specialists for skin testing and allergen immunotherapy based on evidence and Mexican expert opinion, according to the GRADE system. METHODS The guidelines were developed following the methodology of a guideline for clinical practice starting with the formulation of clinical questions, in the context of Mexican environmental conditions and morbidity, with the participation of allergists from all regions of the country. External validation was obtained. Its development followed three steps: 1. formulation of 24 clinical questions. 2. Search for consensus on the answers among members of the Regional chapters of both Mexican Colleges of Allergists (CMICA and COMPEDIA) during regional meetings. 3. Literature search for articles related to the questions and grading of its quality according to GRADE. RESULTS Based on the regional consensus, 116 articles and the safety, patient acceptance/ comfort and cost clinical recommendations and suggestions were developed on basic aspects of skin testing, subcutaneous and sublingual immunotherapy (patient preparation, vial preparation and application schedules) and the treatment of eventual adverse reactions. CONCLUSIONS A clinical guideline was developed respecting particular methodology, validated by CMICA and COMPEDIA for its implementation among Mexican allergists. Several aspects deserve further study to improve scientific evidence. KEYWORDS Allergen immunotherapy, subcutaneous immunotherapy, sublingual immunotherapy, skin testing, allergy diagnosis, rhinitis, asthma, atopic dermatitis, house dust mite, pollens, anaphylaxis, adrenaline, Mexico.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2011 Jan-Feb </dc:date>
<dc:title xml:lang="es">Guía Mexicana de Práctica Clínica de Inmunoterapia 2011.</dc:title>
<dc:title xml:lang="en">[Mexican clinical practice guidelines of immunotherapy 2011].</dc:title>
<dc:publisher>Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)</dc:publisher>
</metadata>
</record>
</pubmed-document>
